A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity
Diabetes Care · 2024
DOI: 10.2337/dc24-1375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, 2024. Verfasst von Ravi Retnakaran und 9 weiteren Autor:innen. Beteiligte Einrichtung: Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin-Secreting Cells, Blood Glucose, Insulin. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Canadian Institutes of Health Research (CIHR).
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE Alleviation of unrecognized glucotoxicity, with resultant recovery of β-cell function, could amplify the glucose-lowering effect of pharmacotherapy and contribute to the variable therapeutic response observed among patients with type 2 diabetes (T2D). However, clinical evidence supporting this concept is lacking. Short-term intensive insulin therapy (IIT) can ameliorate glucotoxicity and improve β-cell function in early T2D. Thus, for evidence of recovery of glucotoxicity-associated β-cell dysfunction, we sought to determine whether there exists a baseline fasting glucose threshold above which the post-IIT improvement in both β-cell function and glycemia is amplified. RESEARCH DESIGN AND METHODS IIT (glargine, lispro) was administered for 3 weeks to 108 adults with T2D (mean duration 1.8 ± 1.4 years). Oral glucose tolerance tests before and after IIT enabled assessment of β-cell function by Insulin Secretion-Sensitivity Index-2 and insulinogenic index/HOMA-insulin resistance. For each level of baseline fasting glycemia from 6.0 to 10.5 mmol/L, we modeled the difference in IIT-induced percentage change in β-cell function between those at/above the indicated glucose level and those below it. RESULTS The relationship between baseline fasting glucose and the differential change in β-cell function was nonlinear. Instead, this relationship was best fit by a cubic regression model with inflection (amplification) at fasting glucose at 9.3 mmol/L. Moreover, baseline fasting glucose at 9.3 mmol/L also identified the inflection point at which nonlinear reductions in fasting glucose and 2-h glucose, respectively, were both amplified. CONCLUSIONS The respective improvements in β-cell function and glycemia in response to short-term IIT are amplified in those in whom baseline fasting glucose exceeds a defined threshold, consistent with reversal of glucotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.
- Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada.
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
- Department of Family Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
- Division of Endocrinology, McMaster University, Hamilton, Ontario, Canada.
ORCID-Profile: Ravi Retnakaran, Hertzel C Gerstein, Natalia McInnes, Caroline K Kramer, Bernard Zinman
Förderung
- Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Retnakaran, R., Pu, J., Ye, C., Emery, A., Harris, S. B., Reichert, S. M., Gerstein, H. C., McInnes, N., Kramer, C. K., & Zinman, B. (2024). A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity. Diabetes Care. https://doi.org/10.2337/dc24-1375
Vancouver
Retnakaran R, Pu J, Ye C, Emery A, Harris SB, Reichert SM, et al. A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity. Diabetes Care. 2024. doi:10.2337/dc24-1375
BibTeX
@article{Retnakaran2024,
author = {Retnakaran, Ravi and Pu, Jiajie and Ye, Chang and Emery, Alexandra and Harris, Stewart B and Reichert, Sonja M and Gerstein, Hertzel C and McInnes, Natalia and Kramer, Caroline K and Zinman, Bernard},
title = {A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity},
journal = {Diabetes Care},
year = {2024},
doi = {10.2337/dc24-1375}
}
EUVIMED